Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a

M Hentrich1, L Maretta, K U Chow

  • 1Department of Hematology/Oncology, Hospital Harlaching, Munich, Germany. tumorzentrum.hentrich@khmh.de